CorePlus and Ibex show real world success with AI for routine cancer diagnosis.
CorePlus and Ibex show real world success with AI for routine cancer diagnosis
Published on January 5, 2024Publications
CorePlus partners with Alpenglow Biosciences and positions itself as a leader in the new era of 3D pathology
The innovation will enable pathologists to improve accuracy in diagnosing prostate cancer.Press ReleasesHealth Industry Summit 2024 by the Puerto Rico Manufacturers Association
Mariano de Socarraz, founder and CEO of CorePlus, during the Health Industry Summit 2024 of the Puerto Rico Manufacturers Association.…EventsUnprecedented Patient Care: CorePlus Uses AI for 100% QC in Cervical Cytology
Insights into the shift from manual microscopy to digital diagnostics using Techcyte's AI platform.Videos